WO2002002084A8 - Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture - Google Patents
Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufactureInfo
- Publication number
- WO2002002084A8 WO2002002084A8 PCT/US2001/020319 US0120319W WO0202084A8 WO 2002002084 A8 WO2002002084 A8 WO 2002002084A8 US 0120319 W US0120319 W US 0120319W WO 0202084 A8 WO0202084 A8 WO 0202084A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cross
- amylose starch
- high amylose
- linked high
- controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B33/00—Preparation of derivatives of amylose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Abstract
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020027018039A KR100840393B1 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufactures |
CA002414349A CA2414349C (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
EP01950498A EP1305009B1 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
BRPI0112140A BRPI0112140B8 (en) | 2000-06-29 | 2001-06-26 | controlled release tablet, process for the manufacture, in an aqueous medium, of a controlled release excipient and cross-linked high amylose starch. |
HU0301302A HUP0301302A2 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and process for its manufacture |
PL365634A PL202177B1 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
DE60120413T DE60120413T2 (en) | 2000-06-29 | 2001-06-26 | CROSS-LINKED STRONG AMYLOSE-CONTAINING STARCH FOR USE IN PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE AND METHOD FOR THE PRODUCTION THEREOF |
SI200130611T SI1305009T1 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
AU2001271481A AU2001271481B2 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
AU7148101A AU7148101A (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
JP2002506706A JP5025066B2 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch used in sustained-release pharmaceutical preparations and method for producing the same |
MXPA03000035A MXPA03000035A (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture. |
IL15365401A IL153654A0 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
NZ523644A NZ523644A (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
IL153654A IL153654A (en) | 2000-06-29 | 2002-12-25 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
NO20026254A NO20026254L (en) | 2000-06-29 | 2002-12-27 | Controlled Release Tablet, Controlled Release Excipient Preparation, and Cross-linked Hoyamylose Starch. |
HK04102459A HK1059574A1 (en) | 2000-06-29 | 2004-04-06 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/606,399 US6607748B1 (en) | 2000-06-29 | 2000-06-29 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
US09/606,399 | 2000-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002002084A1 WO2002002084A1 (en) | 2002-01-10 |
WO2002002084A8 true WO2002002084A8 (en) | 2002-04-04 |
Family
ID=24427807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/020319 WO2002002084A1 (en) | 2000-06-29 | 2001-06-26 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
Country Status (27)
Country | Link |
---|---|
US (2) | US6607748B1 (en) |
EP (1) | EP1305009B1 (en) |
JP (1) | JP5025066B2 (en) |
KR (1) | KR100840393B1 (en) |
CN (1) | CN100352509C (en) |
AR (1) | AR029549A1 (en) |
AT (1) | ATE328585T1 (en) |
AU (2) | AU2001271481B2 (en) |
BR (1) | BRPI0112140B8 (en) |
CA (1) | CA2414349C (en) |
CZ (1) | CZ300152B6 (en) |
DE (1) | DE60120413T2 (en) |
DK (1) | DK1305009T3 (en) |
ES (1) | ES2272499T3 (en) |
HK (1) | HK1059574A1 (en) |
HU (1) | HUP0301302A2 (en) |
IL (2) | IL153654A0 (en) |
MX (1) | MXPA03000035A (en) |
MY (1) | MY128308A (en) |
NO (1) | NO20026254L (en) |
NZ (1) | NZ523644A (en) |
PL (1) | PL202177B1 (en) |
PT (1) | PT1305009E (en) |
RU (1) | RU2274443C2 (en) |
SI (1) | SI1305009T1 (en) |
TW (1) | TWI289460B (en) |
WO (1) | WO2002002084A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010028489A1 (en) * | 2008-09-15 | 2010-03-18 | Labopharm Inc. | Starch-based microparticles for the release of agents disposed therein |
US8962019B2 (en) | 2005-09-09 | 2015-02-24 | Angelini Pharma, Inc. | Sustained drug release composition |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL119660A (en) | 1993-05-10 | 2002-09-12 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
EP1162890B1 (en) * | 1998-10-30 | 2005-10-12 | RJ Innovation | A method of preventing parturient hypocalcemia in animals and compositions used therein |
US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
FR2822471B1 (en) * | 2001-03-26 | 2003-06-13 | Roquette Freres | METHOD OF COOKING / DRYING AMYLOSE-RICH STARCHES |
AU2002348105A1 (en) * | 2001-10-29 | 2003-05-12 | King Pharmaceuticals Research And Development, Inc | Oral dosage forms for improving the bioavailability of therapeutic agents |
US7815936B2 (en) * | 2001-10-30 | 2010-10-19 | Evonik Degussa Gmbh | Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
US6949256B2 (en) * | 2002-01-18 | 2005-09-27 | Banner Pharmacaps, Inc. | Non-gelatin capsule shell formulation |
US7887838B2 (en) * | 2002-01-18 | 2011-02-15 | Banner Pharmacaps, Inc. | Non-gelatin film and method and apparatus for producing same |
US8128957B1 (en) | 2002-02-21 | 2012-03-06 | Valeant International (Barbados) Srl | Modified release compositions of at least one form of tramadol |
RU2336864C2 (en) * | 2002-03-22 | 2008-10-27 | Цилаг Аг | Tramadol dosage bands with sustained release |
US20030191029A1 (en) * | 2002-03-28 | 2003-10-09 | Elementis Specialties, Inc. | Aqueous-based oil well drilling fluids containing high amylose starch polymers |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
BR0315657A (en) * | 2002-10-25 | 2005-09-13 | Labopharm Inc | Solid dosage formulation, controlled release tablet, method of manufacturing a controlled release medication, pharmaceutical composition and use of a composition |
MY142195A (en) * | 2002-10-25 | 2010-10-15 | Labopharm Inc | Controlled-release compositions |
TWI319713B (en) * | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) * | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
KR20050083816A (en) * | 2002-10-25 | 2005-08-26 | 라보팜 인코포레이트 | Sustained-release tramadol formulations with 24-hour efficacy |
US6846497B2 (en) * | 2003-01-30 | 2005-01-25 | National Starch And Chemical Investment Holding Corporation | Rapidly expanding starches with altered crystalline structure |
US20050008677A1 (en) * | 2003-04-14 | 2005-01-13 | Fmc Corporation | Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan |
US20050019295A1 (en) * | 2003-04-14 | 2005-01-27 | Fmc Corporation | Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |
US7816341B2 (en) * | 2003-04-14 | 2010-10-19 | Fmc Corporation | Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom |
JP2006524743A (en) * | 2003-04-14 | 2006-11-02 | エフ エム シー コーポレーション | Uniform thermoreversible alginate film and soft capsule made therefrom |
US20050048185A1 (en) * | 2003-04-14 | 2005-03-03 | Fmc Corporation | Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films |
US20050019294A1 (en) * | 2003-04-14 | 2005-01-27 | Fmc Corporation | Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
US20050013847A1 (en) * | 2003-04-14 | 2005-01-20 | Fmc Corporation | Delivery systems of homogeneous, thermoreversible alginate films |
EP1479381A1 (en) * | 2003-05-19 | 2004-11-24 | Euro-Celtique S.A. | Pharmaceutical dosage form comprising a solid solution |
DE10336400A1 (en) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Anti-abuse dosage form |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10361596A1 (en) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
DE102005005446A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Break-resistant dosage forms with sustained release |
US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
JP2007533733A (en) * | 2004-04-22 | 2007-11-22 | モル リサーチ アプリケーションズ リミテッド | How to control food intake |
DE102004032049A1 (en) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Anti-abuse, oral dosage form |
CA2491665A1 (en) * | 2004-12-24 | 2006-06-24 | Louis Cartilier | Tablet formulation for the sustained release of active substances |
DE102005005449A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
US20060188631A1 (en) * | 2005-02-18 | 2006-08-24 | Kyungsoo Woo | Pregelatinized chemically modified resistant starch products and uses thereof |
US20070190141A1 (en) * | 2006-02-16 | 2007-08-16 | Aaron Dely | Extended release opiate composition |
CN100437113C (en) * | 2006-04-11 | 2008-11-26 | 汪运山 | Kit for detecting concentration ratio of phenacetin and acetaminophen in blood and application thereof |
WO2009018169A1 (en) * | 2007-07-27 | 2009-02-05 | Auspex Pharmaceuticals, Inc. | Substituted cyclohexanols |
RU2445320C2 (en) * | 2007-08-31 | 2012-03-20 | Сирал Бельгия Нв | Method of producing cold water swelling gelled starch cross-linked with phosphate |
AU2008314454A1 (en) * | 2007-10-16 | 2009-04-23 | Labopharm (Barbados) Limited | Bilayer composition for the sustained release of acetaminophen and tramadol |
GB0722484D0 (en) * | 2007-11-15 | 2007-12-27 | Ucl Business Plc | Solid compositions |
BRPI0821732A2 (en) | 2007-12-17 | 2015-06-16 | Labopharm Inc | Controlled release formulations, solid dosage form, and use of controlled release formulation |
PL2234607T3 (en) * | 2007-12-28 | 2011-12-30 | Acraf | A slow-release formulation based on an association of glycogen and alginate |
RU2493830C2 (en) | 2008-01-25 | 2013-09-27 | Грюненталь Гмбх | Drug form |
ES2384305T3 (en) * | 2008-02-19 | 2012-07-03 | Mcneil-Ppc, Inc. | Immersion coating compositions containing a starch with high amylose content |
AU2009243681B2 (en) | 2008-05-09 | 2013-12-19 | Grunenthal Gmbh | Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step |
US20100003322A1 (en) * | 2008-07-03 | 2010-01-07 | Lai Felix S | Enteric coated hydrophobic matrix formulation |
ES2425762T3 (en) * | 2008-10-27 | 2013-10-17 | Roquette Freres | Water insoluble polymer: film coatings based on modified starch derivatives for colon-directed release |
AU2009327312A1 (en) | 2008-12-16 | 2011-08-04 | Labopharm Europe Limited | Misuse preventative, controlled release formulation |
EP2389163B1 (en) | 2009-01-23 | 2021-09-01 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. - S.p.A. | Controlled release pharmaceutical or food formulation and process for its preparation |
EP2997965B1 (en) | 2009-07-22 | 2019-01-02 | Grünenthal GmbH | Tamper-resistant dosage form for oxidation-sensitive opioids |
PL2456427T3 (en) | 2009-07-22 | 2015-07-31 | Gruenenthal Gmbh | Hot-melt extruded controlled release dosage form |
CA2775890C (en) * | 2009-09-30 | 2016-06-21 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
ES2606227T3 (en) | 2010-02-03 | 2017-03-23 | Grünenthal GmbH | Preparation of a pharmaceutical powder composition by an extruder |
RU2012138046A (en) | 2010-02-07 | 2014-03-20 | Клиэфарма Индастриз Лтд. | NUTA AND ITS APPLICATION |
EP2386297A1 (en) * | 2010-04-28 | 2011-11-16 | Roquette Frères | Indigestible polymer: starch acetate -based film coatings for colon targeting |
BR112013000190A2 (en) * | 2010-07-06 | 2017-11-07 | Gruenenthal Gmbh | gastric retention dosage forms comprising a gaba analogue and an opioid |
MX2013002377A (en) | 2010-09-02 | 2013-04-29 | Gruenenthal Gmbh | Tamper resistant dosage form comprising inorganic salt. |
TWI516286B (en) | 2010-09-02 | 2016-01-11 | 歌林達股份有限公司 | Tamper resistant dosage form comprising an anionic polymer |
WO2012072665A1 (en) | 2010-11-30 | 2012-06-07 | Pharmaneuroboost N.V. | Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors |
LT2736495T (en) | 2011-07-29 | 2017-11-10 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
BR112014001091A2 (en) | 2011-07-29 | 2017-02-14 | Gruenenthal Gmbh | tamper resistant tablet that provides immediate release of the drug |
WO2013025572A1 (en) * | 2011-08-12 | 2013-02-21 | Rutgers, The State University Of New Jersey | An interpolymer network delivery system |
BR112014019988A8 (en) | 2012-02-28 | 2017-07-11 | Gruenenthal Gmbh | BREAK-RESISTANT DOSAGE FORM COMPRISING A PHARMACOLOGICALLY ACTIVE COMPOUND AND AN ANIONIC POLYMER |
AR090695A1 (en) | 2012-04-18 | 2014-12-03 | Gruenenthal Gmbh | PHARMACEUTICAL DOSAGE FORM RESISTANT TO ADULTERATION AND RESISTANT TO IMMEDIATE RELEASE OF DOSE |
GB201207907D0 (en) | 2012-05-04 | 2012-06-20 | E Therapeutics Plc | Treatment of depression |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
EP3446685A1 (en) | 2012-11-30 | 2019-02-27 | Acura Pharmaceuticals, Inc. | Self-regulated release of active pharmaceutical ingredient |
CN103070845B (en) * | 2013-01-14 | 2014-10-22 | 北京爱特康科贸有限责任公司 | Starch hollow capsule and preparation method thereof |
CA2907950A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper-resistant dosage form containing one or more particles |
JP6466417B2 (en) | 2013-05-29 | 2019-02-06 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | A tamper-resistant dosage form with a bimodal release profile |
MX368846B (en) | 2013-07-12 | 2019-10-18 | Gruenenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer. |
CA2931553C (en) | 2013-11-26 | 2022-01-18 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
EP3122336A4 (en) | 2014-03-26 | 2017-10-25 | Sun Pharma Advanced Research Company Ltd | Abuse deterrent immediate release biphasic matrix solid dosage form |
CA2947786A1 (en) | 2014-05-12 | 2015-11-19 | Grunenthal Gmbh | Tamper resistant immediate release capsule formulation comprising tapentadol |
EP3148512A1 (en) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
GB201413832D0 (en) * | 2014-08-05 | 2014-09-17 | Tate & Lyle Ingredients | Starch compositions useful for thickening aqueous liquids |
US10982013B2 (en) | 2014-06-02 | 2021-04-20 | Anavo Technologies, Llc | Modified biopolymers and methods of producing and using the same |
EP3285745A1 (en) | 2015-04-24 | 2018-02-28 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
JP2018526414A (en) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Protection against oral overdose with abuse-inhibiting immediate release formulations |
CA3004346A1 (en) | 2015-11-23 | 2017-06-01 | Tethis, Inc. | Coated particles and methods of making and using the same |
CN106337030A (en) * | 2016-08-24 | 2017-01-18 | 宁波枫叶杰科生物技术有限公司 | Microbial product for treatment of heavy metal polluted saline-alkaline land and manufacture method thereof |
JP6216088B1 (en) * | 2017-04-21 | 2017-10-18 | 森永製菓株式会社 | Oral sustained release composition and method for producing the same |
GB2567493B (en) * | 2017-10-13 | 2019-12-18 | Altus Formulation Inc | Starch-based release modifying excipients and pharmaceutical compositions derived therefrom |
CN113121709B (en) * | 2019-12-30 | 2022-08-26 | 仙乐健康科技股份有限公司 | Preparation method and application of modified starch |
CN112098408B (en) * | 2020-09-14 | 2022-12-09 | 湖北亿纬动力有限公司 | Detection method for sodium carboxymethylcellulose dissolution effect and application |
CN117530929B (en) * | 2024-01-10 | 2024-03-29 | 东华大学 | Weight-losing capsule |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2938901A (en) | 1954-08-06 | 1960-05-31 | Corn Products Co | Surgical dusting powder and process therefor |
US2987445A (en) | 1958-10-10 | 1961-06-06 | Rohm & Haas | Drug composition |
US3087860A (en) | 1958-12-19 | 1963-04-30 | Abbott Lab | Method of prolonging release of drug from a precompressed solid carrier |
US3034911A (en) | 1959-03-25 | 1962-05-15 | Nat Starch Chem Corp | Tablet disintegrants |
US3453368A (en) | 1966-01-13 | 1969-07-01 | Hoffmann La Roche | Smaller high potency compressed tablets of ascorbic acid |
US3490742A (en) | 1966-01-14 | 1970-01-20 | Staley Mfg Co A E | Compressed tablets |
US3622677A (en) | 1969-07-07 | 1971-11-23 | Staley Mfg Co A E | Compressed tablets containing compacted starch as binder-disintegrant ingredient |
US4072535A (en) | 1970-12-28 | 1978-02-07 | A. E. Staley Manufacturing Company | Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules |
US3904601A (en) * | 1972-12-21 | 1975-09-09 | Nat Starch Chem Corp | Hydroxypropylated, inhibited high amylose retort starches |
US4026986A (en) | 1975-05-22 | 1977-05-31 | The Dow Chemical Company | Capsule shell |
GB1576475A (en) * | 1977-01-19 | 1980-10-08 | Unilever Ltd | Absorbent cross-linked starch materials |
US4308251A (en) | 1980-01-11 | 1981-12-29 | Boots Pharmaceuticals, Inc. | Controlled release formulations of orally-active medicaments |
US4369308A (en) | 1981-07-24 | 1983-01-18 | National Starch And Chemical Corporation | Low swelling starches as tablet disintegrants |
US4818542A (en) | 1983-11-14 | 1989-04-04 | The University Of Kentucky Research Foundation | Porous microspheres for drug delivery and methods for making same |
US4551177A (en) | 1984-04-23 | 1985-11-05 | National Starch And Chemical Corporation | Compressible starches as binders for tablets or capsules |
US4904476A (en) | 1986-03-04 | 1990-02-27 | American Home Products Corporation | Formulations providing three distinct releases |
IT1200178B (en) | 1986-07-23 | 1989-01-05 | Alfa Farmaceutici Spa | GALENIC FORMULATIONS WITH SCHEDULED SALE CONTAINING DRUGS WITH ANTI-FLOGISTIC ACTIVITY |
GB8812490D0 (en) | 1988-05-26 | 1988-06-29 | Agricultural & Food Res | Delayed release formulations |
CA2041774C (en) | 1990-11-27 | 1994-04-19 | Mircea A. Mateescu | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds |
CA2032385A1 (en) | 1990-12-17 | 1992-06-18 | Chung Wai-Chiu | Enzymatically debranched starches as tablet excipients |
WO1994002121A1 (en) | 1992-07-24 | 1994-02-03 | Labopharm Inc. | Cross-linked polyhydroxylic material for enzymatically controlled drug release |
US5616343A (en) * | 1993-03-25 | 1997-04-01 | Labopharm, Inc. | Cross-linked amylose as a binder/disintegrant in tablets |
US5830884A (en) | 1995-01-18 | 1998-11-03 | National Starch And Chemical Investment Holding Corporation | Pharmaceutical products containing thermally-inhibited starches |
JP3949746B2 (en) * | 1996-02-28 | 2007-07-25 | 日澱化學株式会社 | Chemical starch for glass fiber sizing agent |
US5879707A (en) | 1996-10-30 | 1999-03-09 | Universite De Montreal | Substituted amylose as a matrix for sustained drug release |
US5807575A (en) * | 1997-02-14 | 1998-09-15 | Rougier Inc. | Manufacture of cross-linked amylose useful as a excipient for control release of active compounds |
US6284273B1 (en) * | 1998-02-24 | 2001-09-04 | Vincent Lenaerts | Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds |
US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
-
2000
- 2000-06-29 US US09/606,399 patent/US6607748B1/en not_active Expired - Lifetime
-
2001
- 2001-06-26 PL PL365634A patent/PL202177B1/en unknown
- 2001-06-26 JP JP2002506706A patent/JP5025066B2/en not_active Expired - Lifetime
- 2001-06-26 IL IL15365401A patent/IL153654A0/en unknown
- 2001-06-26 AU AU2001271481A patent/AU2001271481B2/en not_active Expired
- 2001-06-26 HU HU0301302A patent/HUP0301302A2/en unknown
- 2001-06-26 AT AT01950498T patent/ATE328585T1/en active
- 2001-06-26 DK DK01950498T patent/DK1305009T3/en active
- 2001-06-26 CA CA002414349A patent/CA2414349C/en not_active Expired - Fee Related
- 2001-06-26 CZ CZ20024269A patent/CZ300152B6/en not_active IP Right Cessation
- 2001-06-26 ES ES01950498T patent/ES2272499T3/en not_active Expired - Lifetime
- 2001-06-26 EP EP01950498A patent/EP1305009B1/en not_active Expired - Lifetime
- 2001-06-26 AU AU7148101A patent/AU7148101A/en active Pending
- 2001-06-26 CN CNB018148638A patent/CN100352509C/en not_active Expired - Fee Related
- 2001-06-26 DE DE60120413T patent/DE60120413T2/en not_active Expired - Lifetime
- 2001-06-26 BR BRPI0112140A patent/BRPI0112140B8/en not_active IP Right Cessation
- 2001-06-26 NZ NZ523644A patent/NZ523644A/en not_active IP Right Cessation
- 2001-06-26 PT PT01950498T patent/PT1305009E/en unknown
- 2001-06-26 WO PCT/US2001/020319 patent/WO2002002084A1/en active IP Right Grant
- 2001-06-26 RU RU2003102438/15A patent/RU2274443C2/en not_active IP Right Cessation
- 2001-06-26 KR KR1020027018039A patent/KR100840393B1/en active IP Right Grant
- 2001-06-26 SI SI200130611T patent/SI1305009T1/en unknown
- 2001-06-26 MX MXPA03000035A patent/MXPA03000035A/en active IP Right Grant
- 2001-06-28 MY MYPI20013087A patent/MY128308A/en unknown
- 2001-06-29 TW TW090115984A patent/TWI289460B/en not_active IP Right Cessation
- 2001-06-29 AR ARP010103143A patent/AR029549A1/en unknown
-
2002
- 2002-12-25 IL IL153654A patent/IL153654A/en active IP Right Grant
- 2002-12-27 NO NO20026254A patent/NO20026254L/en not_active Application Discontinuation
-
2003
- 2003-07-14 US US10/619,983 patent/US20040013726A1/en not_active Abandoned
-
2004
- 2004-04-06 HK HK04102459A patent/HK1059574A1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962019B2 (en) | 2005-09-09 | 2015-02-24 | Angelini Pharma, Inc. | Sustained drug release composition |
WO2010028489A1 (en) * | 2008-09-15 | 2010-03-18 | Labopharm Inc. | Starch-based microparticles for the release of agents disposed therein |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002002084A8 (en) | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture | |
DK0960131T3 (en) | Preparation of cross-linked amylose useful as an excipient for controlled release of active compounds | |
US5085869A (en) | Pharmaceutical granulate | |
JP4402758B2 (en) | Free flowing direct compressed starch as binder, disintegrant and bulking agent for compressed tablets and hard gelatin capsules | |
JP2002012559A5 (en) | ||
AU776662B2 (en) | Coating of tablet cores | |
SI2821067T1 (en) | Rapid dissolution formulation of cinacalcet | |
AU2010202456B2 (en) | Process for making pharmaceutical compositions with a transient plasticizer | |
EP2039349A1 (en) | Solid pharmaceutical composition comprising donepezil hydrochloride | |
BR0012250A (en) | Manufacturing process of masked taste coated granules, and immediate release of the active ingredient, coated granule, fast dissolving multiparticulate tablet and fast hydrodispersible tablet | |
JP2003504324A5 (en) | ||
WO2003055834A3 (en) | Method for the production of $g(a) mannite directly compressible into tablets | |
WO2007109718A3 (en) | Compressed gum and process for the preparation thereof | |
JP2012502902A (en) | Stabilized solid dispersion of adefovir dipivoxil and process for producing the same | |
MXPA04001522A (en) | Method for producing granular coated sodium percarbonate and product obtained according to said method. | |
CA2435714A1 (en) | Fenofibrate tablets | |
AU2571800A (en) | Tablets and process for producing tablets | |
WO2007072497A3 (en) | Stabilized pharmaceutical composition of pramipexole and method of preparation thereof | |
JP2711528B2 (en) | Loxoprofen preparation | |
JP2000016936A (en) | Solid preparation containing loxoprofen sodium | |
AU2002365956A1 (en) | Granulated composition based on starchy substance and non-food and non-pharmaceutical use thereof | |
KR101544943B1 (en) | Tablet composition for modeling pack and method for preparing a modeling pack using thereof | |
JP2002308904A (en) | Method for preparing directly compressible beta- cyclodextrin and directly compressible beta- cyclodextrin prepared thereby | |
JP2002087959A5 (en) | ||
JP2716619B2 (en) | Midodrine hydrochloride-containing preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2414349 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 153654 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2002 506706 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2002-4269 Country of ref document: CZ Ref document number: 1020027018039 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001271481 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/000035 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001950498 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 58/CHENP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 523644 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref country code: RU Ref document number: RU A Ref document number: 2003102438 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018148638 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027018039 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001950498 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-4269 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001271481 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 523644 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 523644 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001950498 Country of ref document: EP |